Literature DB >> 14669822

Serum paraoxonase 1 activity is decreased in thyroid dysfunction.

F Azizi1, F Raiszadeh, M Solati, A Etemadi, M Rahmani, M Arabi.   

Abstract

Changes in serum lipid and lipoprotein concentrations occur frequently in disorders of thyroid function. LDL-cholesterol (LDL-C) oxidation susceptibility is higher in these patients than in normal population. This study aims at assessing lipids, lipoproteins, apolipoproteins and serum paraoxonase 1 (PON1) activity in patients with thyroid dysfunction. Ninety-nine patients with thyroid dysfunction, (49 hypothyroid and 50 hyperthyroid) were compared with 2 separately age- and sex-matched control groups. A fasting blood sample was obtained and serum total cholesterol, triglycerides, apolipoproteins A-I and B, and PON1 activity were measured. In hyperthyroid patients, significantly lower PON1 activity (45 +/- 23 vs 67 +/- 37 IU/ml, p<0.001), triglycerides (112 +/- 53 vs 166 +/- 130 mg/dl, p<0.05), apolipoprotein A-I (137 +/- 26 vs 154 +/- 21 mg/dl, p<0.001) and apolipoprotein B (75 +/- 18 vs 86 +/- 25 mg/dl, p<0.05) were found. Hypothyroid patients had lower PON1 activity (46 +/- 21 vs 64 +/- 32 IU/ml, p<0.005) compared with controls, and higher total cholesterol (224 +/- 69 vs 185 +/- 41 mg/dl, p<0.001), LDL-C (133 +/- 59 vs 93 +/- 36 mg/dl, p<0.001), and apolipoprotein B (107 +/- 37 vs 84 +/- 23 mg/dl, p<0.001). The results show significant changes of lipid levels in thyroid dysfunction. In addition, a significant reduction in PON1 activity was observed in both hyper- and hypothyroid patients. Increased LDL-C oxidation in thyroid dysfunction observed in other studies, at least to some extent, can be attributed to reduced PON1 activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669822     DOI: 10.1007/BF03347350

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  46 in total

1.  Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation.

Authors:  V Sundaram; A N Hanna; L Koneru; H A Newman; J M Falko
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

2.  Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction.

Authors:  S Sen-Banerjee; X Siles; H Campos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

3.  Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism.

Authors:  K C Tan; S W Shiu; A W Kung
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

4.  Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects.

Authors:  H A Kleinveld; A H Naber; A F Stalenhoef; P N Demacker
Journal:  Free Radic Biol Med       Date:  1993-09       Impact factor: 7.376

5.  Experimental hyperthyroidism in man: effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase.

Authors:  P Hansson; S Valdemarsson; P Nilsson-Ehle
Journal:  Horm Metab Res       Date:  1983-09       Impact factor: 2.936

6.  Serum lipoprotein and apolipoprotein concentrations in patients with hyperthyroidism and the effect of treatment with carbimazole.

Authors:  J Boberg; P A Dahlberg; B Vessby; H Lithell
Journal:  Acta Med Scand       Date:  1984

7.  Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.

Authors:  F Pazos; J J Alvarez; J Rubiés-Prat; C Varela; M A Lasunción
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

8.  Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism.

Authors:  S Valdemarsson; P Hedner; P Nilsson-Ehle
Journal:  Eur J Clin Invest       Date:  1982-10       Impact factor: 4.686

9.  Superoxide radical generation, NADPH oxidase activity, and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation.

Authors:  V Fernández; X Barrientos; K Kipreos; A Valenzuela; L A Videla
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

10.  Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment.

Authors:  E Muls; V Blaton; M Rosseneu; E Lesaffre; G Lamberigts; P De Moor
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

View more
  10 in total

1.  Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients.

Authors:  Mehrdad Solati; Hamid-Reza Mahboobi
Journal:  J Nephropathol       Date:  2012-10-01

Review 2.  Thyroid nodules and thyroid autoimmunity in the context of environmental pollution.

Authors:  Salvatore Benvenga; Alessandro Antonelli; Roberto Vita
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

3.  Pleiotropic effects of thyroid hormones: learning from hypothyroidism.

Authors:  Martha Franco; Edmundo Chávez; Oscar Pérez-Méndez
Journal:  J Thyroid Res       Date:  2011-06-27

Review 4.  Thyroid hormones and antioxidant systems: focus on oxidative stress in cardiovascular and pulmonary diseases.

Authors:  Antonio Mancini; Sebastiano Raimondo; Chantal Di Segni; Mariasara Persano; Giovanni Gadotti; Andrea Silvestrini; Roberto Festa; Luca Tiano; Alfredo Pontecorvi; Elisabetta Meucci
Journal:  Int J Mol Sci       Date:  2013-12-09       Impact factor: 5.923

Review 5.  Thyroid Hormones, Oxidative Stress, and Inflammation.

Authors:  Antonio Mancini; Chantal Di Segni; Sebastiano Raimondo; Giulio Olivieri; Andrea Silvestrini; Elisabetta Meucci; Diego Currò
Journal:  Mediators Inflamm       Date:  2016-03-08       Impact factor: 4.711

6.  Thyroid Hormones in Conventional and Organic Farmers in Thailand.

Authors:  Pornpimol Kongtip; Noppanun Nankongnab; Nichcha Kallayanatham; Ritthirong Pundee; Nattagorn Choochouy; Jutharak Yimsabai; Susan Woskie
Journal:  Int J Environ Res Public Health       Date:  2019-07-29       Impact factor: 3.390

7.  Novel associations of nonstructural Loci with paraoxonase activity.

Authors:  Ellen E Quillen; David L Rainwater; Thomas D Dyer; Melanie A Carless; Joanne E Curran; Matthew P Johnson; Harald H H Göring; Shelley A Cole; Sue Rutherford; Jean W Maccluer; Eric K Moses; John Blangero; Laura Almasy; Michael C Mahaney
Journal:  J Lipids       Date:  2012-04-17

8.  Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case-control study.

Authors:  Marwa S Al-Naimi; Nawar R Hussien; Huda A Rasheed; Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Adv Pharm Technol Res       Date:  2018 Jul-Sep

9.  Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates.

Authors:  Anita Bosak; Aljoša Bavec; Tilen Konte; Goran Šinko; Zrinka Kovarik; Marko Goličnik
Journal:  Molecules       Date:  2020-01-04       Impact factor: 4.411

Review 10.  The Role of PON1 Variants in Disease Susceptibility in a Turkish Population.

Authors:  Mahmoud Abudayyak; Tuğçe Boran; Rumeysa Tukel; Ezgi Oztas; Gül Özhan
Journal:  Glob Med Genet       Date:  2020-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.